Physician profile
James Doyle Gentry
NPI 1063606390
$697.88
in general payments reported to CMS, 2019-2025
8 companies · $130 in 2025
The $130 reported for 2025 was more than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2020: $10.23 · 2023: $111 · 2024: $241 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $261 · Education: $105 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $83.08 · Honoraria: $33.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $261.02 |
| Education | $104.88 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $83.08 |
| Honoraria | $33.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nobel Biocare USA | $304.71 | 2019-2023 | Nobelactive |
| Colgate Oral Pharmaceuticals, INC. | $122.98 | 2024 | |
| Dentsply Sirona INC | $113.75 | 2019-2024 | Implant Dentistry |
| Septodont INC. | $83.08 | 2025 | Bioroot Flow Sample, Bufferpro |
| Benco Dental Supply Co. | $33.19 | 2025 | |
| Align Technology, INC. | $15.80 | 2024 | Invisalign |
| Philips North America LLC | $14.14 | 2025 | Oral Health Care Undivided |
| Ivoclar Vivadent, INC. | $10.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Gentry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.